TAVI Market Clinical Research Analysis 2020 to 2030
The TAVI Market is expected togrow at a CAGR of 14.5% from 2020-2030, according to a new research report by NextMove Strategy Consulting
TAVI isalso known as transcatheter aortic valve implantation is a minimally invasiveprocedure used for the implantation of artificial aortic valve. This procedureis done to replace the dysfunctional or damaged heart valve to restore thenormal functioning and prevent further damage to other organs. TAVI is used forthe treatment of valvular heart disease diagnosed by electrocardiography. It isone of the new techniques highly preferred by professionals. TAVI is generallyperformed on high risk patients who cannot undergo surgical valve replacementprocedure.
Accordingto the report, high prevalence rate of cardiovascular disorders, aorticstenosis and rising demand for minimally invasive procedures are driving the marketgrowth. The presence of large geriatric population around the globe, who areprone to heart diseases another factor driving the market growth. Over theperiod of time, there has been constant development in healthcare services alongwith technological advancement in medical devices. Also, high recovery andsurvival rates as compared to other surgical procedures has led to increasedadoption of TAVI. On the other hand, growth in market investments by marketplayers as well as rising healthcare expenditure is likely bring changes inmarket trends.
However, highcost associated with TAVI along with stringent regulatory policies for theapproval of transcatheter aortic valves is likely to impede the market growth. Moreover,growth in research & development activities followed by innovation &product launches is anticipated to provide numerous opportunities to the marketplayers in the coming few years.
On thebasis of procedure, the TAVI market share is segmented into TransfemoralImplantation, Transapical Implantation, and Transaortic Implantation. TransfemoralImplantation dominates the global TAVI market and will be the dominant duringthe forecast period. Transfemoral implantation is one of the highly accepted techniqueswith minimal aesthesia and high accuracy as compared to other procedures.
NorthAmerica accounts for the highest market size & share in the TAVI market throughoutthe forecast period, owing to the presence of developed healthcare facilities& infrastructure. In addition, technological advancements as well aspresence of major market players in the region is expected to promote marketgrowth. Europe holds the second largest market size in the TAVI market. AsiaPacific is expected to be the fastest developing region in the TAVI marketmajorly driven by the high prevalence rate of cardiovascular disorders as wellas presence of large geriatric population prone to cardiovascular disorders. Additionally,favourable reimbursement policies as well as growth in TAVI procedures in theregion are also expected to fuel the market growth.
According to the report, some the key players in the TAVI market report areAbbott Laboratories, JC Medical, Inc., Meril Life Sciences Pvt. Ltd.,BraccoS.p.A. (HLT, Inc.), Boston Scientific Corporation (Symetis SA), JenaValveTechnology, Inc., Edwards Lifesciences Corporation, Medtronic plc, VenusMedtech, Inc and NVT AG.
Browse keyindustry insights from the report, “TAVIMarket Size By Procedure (TransfemoralImplantation, Transapical Implantation, and Transaortic Implantation) RegionalOutlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India,Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, SouthAfrica, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, CompetitiveMarket Share & Forecast, 2020–2030” in detail along with the tableof contents:
Key Insights from the TAVI Market Report:
- Asia Pacific is the fastest growing region in TAVI market owing to the high prevalence rate of cardiovascular disorders, presence of large geriatric population and favourable reimbursement scenario.
- The Transfemoral Implantationsegment dominates the market in terms of procedure and is expected to grow at asignificant CAGR to maintain the lead till 2030.
- Some of the major players in the market are Abbott Laboratories, JC Medical, Inc., Meril Life Sciences Pvt. Ltd., BraccoS.p.A. (HLT, Inc.), Boston Scientific Corporation (Symetis SA), JenaValve Technology, Inc., Edwards Lifesciences Corporation, Medtronic plc, Venus Medtech, Inc and NVT AG.
The report TAVI market – segmented byprocedure, and geography
Get a free sample on the TAVI Market report
About NextMove Strategy Consulting
Next Move Strategy Consulting is an independent and trustedthird-platform market intelligence provider, committed to deliver high quality,market research reports that help multinational companies to triumph over theircompetitions and increase industry footprint by capturing greater market share.Our research model is a unique collaboration of primary research, secondaryresearch, data mining and data analytics.
We have been servicing over 1000 customers globally thatincludes 90% of the Fortune 500 companies over a decade. Our analysts areconstantly tracking various high growth markets and identifying hiddenopportunities in each sector or the industry. We provide one of the industry’sbest quality syndicate as well as custom research reports across 10 differentindustry verticals. We are committed to deliver high quality research solutionsin accordance to your business needs. Our industry standard delivery solutionthat ranges from the pre consultation to after-sales services, provide anexcellent client experience and ensure right strategic decision making forbusinesses.
For more insights, please visit,
https://www.nextmsc.comTAVI Market
